In drug development, time lost is literally money lost and every day of delay can potentially cost millions. People in the industry are exploring new strategies to get drugs to market faster with potentially fewer patients, as Pina D’Angelo, VP of Biometrics at Innovaderm, pointed out. Adaptive clinical trial designs can be a notable tool…